NCT07130916
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07130916
Title A Study of Aumolertinib in European Participants With Non-Small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Jiangsu Hansoh Pharmaceutical Co., Ltd.
Indications
Therapies
Age Groups: senior | adult
Covered Countries BGR


No variant requirements are available.